Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
-742K
-
Total reported value, excl. options
-
$139M
-
Value change
-
-$8.01M
-
Number of buys
-
31
-
Number of sells
-
-29
-
Price
-
$6.62
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q4 2023
72 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 44.5M outstanding shares and own 47.06% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), ORBIMED ADVISORS LLC (2.84M shares), First Light Asset Management, LLC (2.55M shares), AIGH Capital Management LLC (1.38M shares), Nantahala Capital Management, LLC (1.1M shares), BlackRock Inc. (1.08M shares), VANGUARD GROUP INC (999K shares), Pentwater Capital Management LP (990K shares), SILVERARC CAPITAL MANAGEMENT, LLC (795K shares), and FEDERATED HERMES, INC. (712K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.